Tag: hemostatic agents market opportunities

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Hemostatic Agents Market Forecast: Value Set To Climb From $4.66 Billion To $5.71 Billion

The hemostatic agents market size has seen robust expansion in recent years. This market is expected to grow from $4.42 billion in 2025 to $4.66 billion in 2026, at a compound annual growth rate (CAGR) of 5.4%. The historical period’s growth can be attributed to a limited variety of hemostatic agents, a reliance on traditional thrombin and gelatin products, an increasing number of surgical procedures, expanding hospital infrastructure, and a growing awareness of blood loss management.

The hemostatic agents market size is projected to experience substantial expansion in the coming years. It is anticipated to reach $5.71 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This anticipated growth during the forecast period is primarily driven by factors such as the advancement of recombinant and sprayable fibrin sealants, the increasing scope of minimally invasive and orthopedic surgical procedures, a surge in the need for multi-agent and combination hemostats, greater uptake in plastic and neurosurgery, and regulatory focus on ensuring sterility and biocompatibility. Key trends defining this period encompass a growing requirement for sophisticated hemostatic agents in surgical settings, wider acceptance of combination and multi-agent hemostats, an increase in the utilization of fibrin sealants and biologically derived solutions, broadened application of hemostats in trauma and cardiovascular operations, and a heightened commitment to safety, sterility, and adherence to regulations.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=81920753&type=smp&name=Hemostatic%20Agents%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hemostatic Agents Market Demand Drivers: What’s Powering Industry Growth?

The expanding volume of surgical procedures is projected to spur the growth of the hemostatic agents market moving forward. Surgical procedures encompass medical interventions performed by health professionals utilizing specific instruments to address, repair, or excise parts of the body for health-related objectives. This increase in surgical procedures is largely attributed to the growing prevalence of chronic conditions, which often necessitate surgical intervention to manage health issues and improve patient outcomes. Hemostatic agents are vital in surgeries, as they facilitate rapid bleeding control, thereby reducing blood loss and improving visibility within the surgical area for more precise work. For instance, in October 2025, according to the UK Health Security Agency (UKHSA), a UK-based national government public health agency, surveillance data from the 2023–24 period revealed that 135,619 operations were submitted, with 1,276 surgical site infections (SSIs) detected during inpatient stay or upon readmission, marking an 8.4% increase in submissions compared to the previous year. Therefore, the rising number of surgical procedures is driving the expansion of the hemostatic agents market.

Hemostatic Agents Market Segment Analysis Spotlighting Growth Areas

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

Hemostatic Agents Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading companies in the hemostatic agents market are concentrating on developing sophisticated solutions, such as collagen-based hemostats, to provide quick and effective hemostasis and tissue closure for both open and minimally invasive surgeries. Collagen-based hemostats are materials derived from purified collagen that help stop bleeding by enhancing the body’s natural clotting process at a wound or surgical incision site. For instance, in March 2025, Baxter, a US-based healthcare company, unveiled HEMOPATCH Sealing Hemostat, an absorbable pad based on collagen. This innovative collagen-based pad incorporates a dual-action system that combines a collagen matrix with an NHS-PEG layer, which forms a hydrogel upon contact with moisture, facilitating rapid sealing of bleeding areas. It offers strong adherence to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less effective. The patch provides hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical processes. Additionally, it naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, meeting critical clinical and storage needs.

Hemostatic Agents Market Key Players Shaping Industry Direction

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z‑Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

View The Full Hemostatic Agents Market Report:

https://thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hemostatic Agents Market Regional Analysis: Which Region Leads By Revenue?

North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The market for hemostatic agents has witnessed significant growth recently, driven by evolving medical needs and advancements in surgical techniques. With increasing surgical procedures and rising demand for innovative products, this sector is positioned for continued expansion. Below, we explore the current market size, key growth drivers, segmentation, strategic developments, and regional outlook for hemostatic agents.

Hemostatic Agents Market Size Projections and Growth Potential

The hemostatic agents market has experienced robust growth over recent years. It is projected to rise from $4.42 billion in 2025 to $4.66 billion in 2026, growing at a compound annual growth rate (CAGR) of 5.4%. This historical growth is largely due to the limited variety of hemostatic agents available, dependence on traditional thrombin and gelatin products, an increasing volume of surgical procedures, expansion in hospital infrastructure, and heightened awareness regarding the management of blood loss.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

Looking ahead, the market is forecasted to continue its upward trajectory, reaching $5.71 billion by 2030 with a CAGR of 5.2%. The anticipated growth is driven by innovations such as recombinant and sprayable fibrin sealants, a surge in minimally invasive and orthopedic surgeries, greater demand for combination and multi-agent hemostats, and increased use in plastic and neurosurgical procedures. The market will also be influenced by stricter regulatory requirements focused on sterility and biocompatibility. Key trends expected to shape the market include rising adoption of advanced hemostatic agents during surgeries, growth in fibrin sealants and biologically sourced products, expanded use in trauma and cardiovascular surgeries, and a stronger emphasis on safety and regulatory compliance.

Growing Number of Surgeries Boosting Hemostatic Agents Demand

One of the primary factors propelling the hemostatic agents market is the rising volume of surgical procedures worldwide. Surgical operations, which involve specialized techniques to treat, repair, or remove bodily tissues, are increasingly performed to address a growing number of chronic health conditions. These procedures often require effective blood loss control, and hemostatic agents play a crucial role in quickly stopping bleeding, reducing blood loss, and improving surgical visibility for precise interventions.

Access The Complete Hemostatic Agents Market Report:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

Supporting this trend, data from the UK Health Security Agency (UKHSA) revealed that during the 2023–24 period, there were 135,619 recorded operations with 1,276 surgical site infections identified, marking an 8.4% increase in reported procedures compared to the prior year. This rise in surgeries directly contributes to greater demand for hemostatic agents.

Detailed Segmentation of the Hemostatic Agents Market

The market for hemostatic agents is categorized based on type, application, and end-user:

By Type:

– Thrombin-Based Hemostats

– Gelatin-Based Hemostats

– Collagen-Based Hemostats

– Oxidized Regenerated Cellulose-Based Hemostats

– Combination Hemostats

– Fibrin Sealants

– Other Types

By Application:

– Trauma

– Cardiovascular Surgery

– General Surgery

– Plastic Surgery

– Orthopedic Surgery

– Neurosurgery

– Other Applications

By End-User:

– Hospitals

– Surgery Centers

– Nursing Homes

– Other End Users

Further subcategories include thrombin-based products like bovine and human thrombin, gelatin-based forms such as absorbable sponges and powders, collagen sponges and sheets, oxidized cellulose pads and meshes, combination agents merging various bases, fibrin sealants including recombinant and sprayable types, and other varieties such as polysaccharide- and synthetic polymer-based hemostats.

Advances in Hemostatic Technology Guiding Market Evolution

Key players in the hemostatic agents industry are concentrating on innovating more efficient products, especially collagen-based hemostats that enable rapid hemostasis and tissue sealing in both open and minimally invasive surgeries. These collagen-based materials work by supporting the body’s natural clotting response at wound sites.

For example, in March 2025, Baxter introduced HEMOPATCH Sealing Hemostat, a collagen-based absorbable pad featuring a dual-action system combining a collagen matrix with an NHS-PEG layer that forms a hydrogel upon contact with moisture. This design allows for fast sealing of bleeding areas, strong adhesion to wet tissues, and suitability for diverse surgical approaches. The patch achieves hemostasis in under two minutes without requiring cold storage or special preparation, simplifying surgical workflows. It also biodegrades naturally within 6 to 8 weeks and can be stored at room temperature for up to three years, fulfilling key clinical and logistical needs.

Prominent Companies Shaping the Hemostatic Agents Industry

The competitive landscape of the hemostatic agents market includes several leading corporations such as Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z‑Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., and Biom’Up SAS.

Regional Perspective and Market Share Insights

In 2025, North America held the largest share of the hemostatic agents market. The market report further analyzes regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of geographic trends and growth opportunities worldwide.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Hemostatic Agents Market During 2026–2030?

The hemostatic agents market has demonstrated robust expansion in recent years. It is forecast to increase from $4.42 billion in 2025 to $4.66 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.4%. The historical development of this market can be attributed to a restricted range of hemostatic agents, a reliance on conventional thrombin and gelatin products, a rising volume of surgical procedures, expanding hospital infrastructure, and enhanced awareness regarding blood loss management.

The hemostatic agents market size is projected to undergo significant expansion in the coming years, with its value expected to reach $5.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth during the forecast period can be attributed to factors such as the innovation of recombinant and sprayable fibrin sealants, an increase in minimally invasive and orthopedic surgical procedures, a rising need for multi-agent and combination hemostats, their increased application in plastic and neurosurgery, and a stronger regulatory emphasis on sterility and biocompatibility. Prominent trends throughout this period include an escalating demand for advanced hemostatic agents in surgical contexts, a growing adoption of combination and multi-agent hemostats, the expansion of fibrin sealants and biologically derived products, wider utilization of hemostats in trauma and cardiovascular surgeries, and an intensified focus on safety, sterility, and regulatory adherence.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

Which Primary Drivers Are Impacting The Hemostatic Agents Market Growth?

The future expansion of the hemostatic agents market is anticipated to be propelled by the rising volume of surgical procedures. Surgical procedures are medical interventions performed by healthcare professionals using specialized instruments to address, repair, or remove parts of the body for health-related purposes. This increase in operations largely stems from the growing prevalence of chronic conditions, often necessitating surgical solutions to manage health problems and enhance patient recovery. Hemostatic agents play a crucial role during surgeries by rapidly arresting bleeding, thereby minimizing blood loss and enhancing surgical field clarity for precise execution. For example, in October 2025, data compiled by the UK Health Security Agency (UKHSA), a UK-based national government public health agency, from the 2023–24 period revealed that 135,619 operations were reported, with 1,276 surgical site infections (SSIs) detected during inpatient stays or upon readmission. This figure marked an 8.4% increase in submissions compared to the prior year. Consequently, the expanding number of surgical procedures is a significant driver of the hemostatic agents market’s growth.

How Are Different Segments Classified In The Hemostatic Agents Market Segment Analysis?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

Which Trends Are Shaping Growth In The Hemostatic Agents Market?

Leading companies active in the hemostatic agents market are concentrating on developing sophisticated solutions, such as collagen-based hemostats, to provide swift and effective hemostasis and tissue closure for both open and minimally invasive surgical procedures. Collagen-based hemostats are hemostatic materials derived from purified collagen that assist in stopping bleeding by augmenting the body’s natural clotting process at the location of a wound or surgical incision. For instance, in March 2025, Baxter, a US-based healthcare company, unveiled HEMOPATCH Sealing Hemostat, a collagen-based absorbable pad. This advanced collagen-based pad integrates a dual-action system that combines a collagen matrix with an NHS-PEG layer, which forms a hydrogel upon contact with moisture, allowing for rapid sealing of bleeding sites. It offers strong adhesion to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less efficacious. The patch achieves hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical processes. Additionally, it naturally dissolves in the body within 6 to 8 weeks and can be kept at room temperature for up to three years, addressing crucial clinical and storage needs.

Who Are The Companies Driving Activity In The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Get The Full Hemostatic Agents Market Report:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

Which Region Leads The Hemostatic Agents Market In Overall Market Size?

North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hemostatic Agents Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hematology Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Hemostatic Agents Market Across 2026–2030?

The hemostatic agents market has demonstrated robust expansion over recent years. It is anticipated to increase from $4.42 billion in 2025 to $4.66 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.4%. This growth in the preceding period can be attributed to a limited variety of hemostatic agents, reliance on traditional thrombin and gelatin products, a rising number of surgical procedures, expanding hospital infrastructure, and greater awareness of blood loss management.

The hemostatic agents market size is forecast to show significant expansion in the coming years. It is predicted to reach $5.71 billion in 2030, progressing at a compound annual growth rate (CAGR) of 5.2%. This growth over the forecast period can be attributed to the development of recombinant and sprayable fibrin sealants, an increase in minimally invasive and orthopedic surgeries, growing demand for multi-agent and combination hemostats, broader adoption in plastic and neurosurgery applications, and regulatory emphasis on sterility and biocompatibility. Key trends identified for the forecast period include a rising demand for advanced hemostatic agents in surgical procedures, increasing adoption of combination and multi-agent hemostats, growth in fibrin sealants and biologically derived products, the expansion of hemostats use in trauma and cardiovascular surgeries, and an enhanced focus on safety, sterility, and regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

Which Market Drivers Are Supporting The Expansion Of The Hemostatic Agents Market?

The projected expansion of the hemostatic agents market is linked to the growing volume of surgical operations anticipated in the future. These operations involve medical interventions carried out by healthcare experts with specific tools to treat, mend, or excise bodily sections for health improvement. This uptick in surgeries primarily stems from a greater incidence of chronic illnesses, frequently necessitating surgical care to handle health concerns and enhance patient recovery. Within surgical settings, hemostatic agents play a crucial role by rapidly controlling hemorrhage, thereby minimizing blood loss and enhancing the clarity of the surgical field for precise procedures. As an illustration, in October 2025, surveillance information from the 2023–24 period, released by the UK Health Security Agency (UKHSA), a UK-based national government public health agency, indicated that 135,619 operations were reported, with 1,276 surgical site infections (SSIs) identified either during hospitalization or upon readmission. This marked an 8.4% rise in reported operations compared to the preceding year. Consequently, the rising volume of surgical interventions is a key stimulant for the expansion of the hemostatic agents market.

What Segmentation Levels Are Considered In The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

What Trends Are Projected To Affect The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are concentrating on developing advanced solutions, such as collagen-based hemostats, to deliver rapid and effective hemostasis and tissue sealing for both open and minimally invasive surgeries. Collagen-based hemostats are hemostatic materials derived from purified collagen, which assist in stopping bleeding by enhancing the body’s natural clotting process at the site of a wound or surgical incision. For instance, in March 2025, Baxter, a US-based healthcare company, launched HEMOPATCH Sealing Hemostat, a collagen-based absorbable pad. This advanced collagen-based pad integrates a dual-action system combining a collagen matrix with an NHS-PEG layer that forms a hydrogel upon contact with moisture, enabling quick sealing of bleeding sites. It provides strong adhesion to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less effective. The patch delivers hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical procedures. It also naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, addressing important clinical and storage requirements.

Which Leading Firms Are Contributing To The Growth Of The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Read the full hemostatic agents market report here:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

How Is The Hemostatic Agents Market Distributed Across Key Geographic Regions?

North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hemostatic Agents Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hematology Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Hemostatic Agents Market covering 2026–2035?

The hemostatic agents market size has demonstrated substantial growth in recent years. A rise is anticipated from $4.42 billion in 2025 to $4.66 billion by 2026, achieving a compound annual growth rate (CAGR) of 5.4%. This historical growth can be linked to a limited assortment of hemostatic agents, the dependence on traditional thrombin and gelatin products, an increase in surgical procedures, developing hospital infrastructure, and an increased awareness of blood loss management.

The hemostatic agents market size is anticipated to undergo substantial growth in the upcoming years. It is projected to reach $5.71 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%. The expansion during this forecast period is attributable to the development of recombinant and sprayable fibrin sealants, an increase in minimally invasive and orthopedic surgeries, a growing demand for multi-agent and combination hemostats, wider adoption in plastic and neurosurgery applications, and a regulatory focus on sterility and biocompatibility. Prominent trends within the forecast timeframe include a rising demand for advanced hemostatic agents in surgical procedures, the increasing utilization of combination and multi-agent hemostats, growth in fibrin sealants and biologically derived products, an expansion of hemostats use in trauma and cardiovascular surgeries, and an enhanced emphasis on safety, sterility, and regulatory compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Hemostatic Agents Market?

The future expansion of the hemostatic agents market is anticipated to be driven by the rising volume of surgical procedures. These procedures involve healthcare professionals performing medical operations with specialized tools to treat, mend, or excise bodily sections for health reasons. This surge in surgeries primarily stems from a growing incidence of chronic conditions, frequently necessitating surgical intervention to address health concerns and enhance patient recovery. During operations, hemostatic agents play a crucial role by rapidly stemming hemorrhage, thereby minimizing blood loss and enhancing surgical field clarity for precise execution. As an illustration, the UK Health Security Agency (UKHSA), a national government public health agency located in the UK, reported surveillance findings for the 2023–24 timeframe in October 2025. This data indicated that 135,619 operations were logged, with 1,276 surgical site infections (SSIs) identified either during hospitalization or upon re-admission, signifying an 8.4% increase in submissions compared to the preceding year. Consequently, the expanding volume of surgical procedures is a key factor propelling the growth of the hemostatic agents market.

What Segments Are Identified Within The Structure Of The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

What Trends Are Driving The Growth Trajectory Of The Hemostatic Agents Market?

Leading companies in the hemostatic agents market are concentrating on developing sophisticated solutions, such as collagen-based hemostats, to ensure swift and effective blood clotting and tissue sealing for both traditional and minimally invasive surgical procedures. These collagen-based hemostats are materials derived from purified collagen designed to help stop bleeding by enhancing the body’s natural coagulation process at the site of an injury or surgical incision. For example, in March 2025, Baxter, a US-based healthcare company, launched HEMOPATCH Sealing Hemostat, an absorbable pad utilizing collagen. This advanced collagen-based pad incorporates a dual-action system that combines a collagen matrix with an NHS-PEG layer, which forms a hydrogel upon contact with moisture, allowing for quick sealing of bleeding areas. It offers strong adhesion to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less effective. The patch provides hemostasis in under two minutes without requiring temperature-controlled storage or specific preparation, thereby streamlining surgical workflows. Additionally, it naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, addressing significant clinical and storage demands.

Which Leading Companies Dominate The Hemostatic Agents Market Share?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z‑Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

How Does The Hemostatic Agents Market Perform Across Major Global Regions?

North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hemostatic Agents Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2026, By The Business Research Company

Hemostats Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hematology Drug Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Hemostasis Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Hemostatic Agents Market Expected To Expand Between 2025 And 2029?

The hemostatic agents market has experienced robust growth in recent years. It is projected to expand from $4.19 billion in 2024 to $4.42 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.5%. This historical expansion can be attributed to an aging global population, an increase in trauma and accident cases, the rising prevalence of cardiovascular disorders, a higher incidence of bleeding disorders such as hemophilia, and a growing number of patients with liver diseases and coagulation defects.

The hemostatic agents market is projected for significant expansion over the coming years, reaching a valuation of $5.43 billion by 2029, driven by a compound annual growth rate (CAGR) of 5.3%. This anticipated growth during the forecast period is primarily due to several factors, including a rise in the volume of surgical procedures, an expansion in minimally invasive surgical techniques, an escalating demand for orthopedic interventions, an increase in cosmetic and aesthetic surgical operations, and the critical requirement for hemostasis during dental surgeries. Key trends influencing the market in this period encompass notable advancements in hemostatic agent formulations, the emergence of bioengineered and recombinant agents, improvements in product shelf-life and stability, the creation of combination products, and the ongoing development of synthetic and absorbable hemostats.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

What Are The Top Growth Drivers Impacting The Hemostatic Agents Market Outlook?

The hemostatic agents market is anticipated to expand due to the rising volume of surgical procedures in the future. These procedures involve medical operations carried out by health professionals with specific tools to treat, mend, or extract body parts for health reasons. A significant factor in this increase is the growing prevalence of chronic conditions, frequently requiring surgery to address health concerns and enhance patient results. Hemostatic agents play a crucial role during surgeries by promptly halting bleeding, thereby lessening blood loss and improving the surgeon’s view in the operating field for greater precision. For example, in March 2023, data from the British Association of Aesthetic Plastic Surgeons (BAAPS), a professional body based in the UK, indicated that 31,057 cosmetic procedures were performed in 2022, marking a 102% surge compared to the prior year. Furthermore, women accounted for 93% of these procedures, representing a 101% increase from 2021. Consequently, the rising volume of surgical interventions is propelling the expansion of the hemostatic agents market.

What Are The Primary Types Of Segments Analyzed In The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

Which Key Trends Are Expected To Influence The Hemostatic Agents Market In The Coming Years?

Major companies in the hemostatic agents market are prioritizing the development of advanced solutions, such as collagen-based hemostats, to deliver rapid and effective control of bleeding and tissue closure for both open and minimally invasive surgeries. Collagen-based hemostats are hemostatic materials extracted from purified collagen that aid in stopping bleeding by enhancing the body’s natural clotting capabilities at the site of a wound or surgical incision. For instance, in March 2025, Baxter, a US-based healthcare company, launched HEMOPATCH Sealing Hemostat, an absorbable pad based on collagen. This sophisticated collagen-based pad utilizes a dual-action mechanism combining a collagen matrix with an NHS-PEG layer that forms a hydrogel upon contact with moisture, allowing for swift sealing of bleeding sites. It offers strong adhesion to wet tissues, rendering it suitable for both open and minimally invasive surgeries where other agents might prove less effective. The patch provides hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical processes. It also naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, thereby meeting important clinical and storage requirements.

Who Are The Primary Competitors In The Global Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

How Does The Hemostatic Agents Market Perform Across Key Geographic Regions?

North America was the largest region in the hemostatic agents market in 2024. The regions covered in the hemostatic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hemostatic Agents Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2025, By The Business Research Company

Hemostasis Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hematology Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Hemostatic Agents Market?

The market for hemostatic agents has experienced vigorous expansion in the recent past. It is expected to escalate from a value of $4.19 billion in 2024 to $4.42 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the historic period include an aging worldwide population, an increase in trauma and accident incidents, a higher prevalence of cardiovascular diseases, a rising occurrence of bleeding disorders, like hemophilia, and an increased patient count for liver diseases and coagulation defects.

Over the coming years, the hemostatic agents market is anticipated to experience substantial growth. A compound annual growth rate (CAGR) of 5.3% is predicted to increase the market to $5.43 billion by 2029. The growth during this forecast period can be attributed to the rise in surgical procedures, growth of minimally invasive surgeries, increased demand for orthopedic surgeries as well as aesthetic and cosmetic surgeries, and the growing necessity for hemostasis in dental surgeries. Key trends for this period include advancements in the formulations of hemostatic agents, introduction of bioengineered and recombinant agents, improvement in product shelf-life and stability, development of combination products, and the creation of synthetic and absorbable hemostats.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

What Are The Primary Factors Supporting The Hemostatic Agents Market Expansion?

The predicted growth of the hemostatic agents market is directly tied to the rising number of surgical procedures. Healthcare professionals carry out surgical operations using specialized equipment to either treat, repair, or remove parts of the body for medical reasons. The need for more surgeries mainly stems from a growing prevalence of chronic conditions, which usually necessitate surgical interference to manage patient health and improve their recovery outcome. Hemostatic agents play a crucial role in surgeries since they aid in stopping blood flow instantly, thus reducing blood loss and increasing visibility, making surgical procedures more accurate. For instance, the British Association of Aesthetic Plastic Surgeons (BAAPS) reported a massive increase of 102% in the number of cosmetic surgeries conducted in 2022 compared to 2021, reaching a total of 31,057 procedures performed in that year alone. Notably, 93% of these procedures were carried out on women, marking a 101% increase since 2021. Hence, the rise in surgical procedures is a significant driver for the expanding hemostatic agents market.

Which Segments Define The Structure Of The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

What Strategic Shifts And Innovations Are Influencing The Hemostatic Agents Market?

Leading organizations in the hemostatic agents market are concentrating on producing innovative solutions, like collagen-based hemostats, to deliver swift and efficient hemostasis and tissue sealing for both extensive and minimally invasive surgery. Collagen-based hemostats are types of hemostatic materials made from refined collagen, which aid in halting bleeding by amplifying the body’s inherent clotting procedure at the wound or surgical cut point. For example, in March 2025, Baxter, a healthcare firm based in the US, unveiled HEMOPATCH Sealing Hemostat, an absorbable pad made of collagen. This enhanced collagen pad features a dual-action setup merging a collagen matrix with an NHS-PEG layer, which transforms into a hydrogel when it comes into contact with moisture, thereby promptly sealing bleeding zones. It strongly adheres to damp tissues, making it ideal for both extensive and minimally invasive surgeries, where other agents might not be as useful. The patch accomplishes hemostasis in under two minutes and does not require temperature-regulated storage or unique preparation, making surgical operations more efficient. Furthermore, it naturally disintegrates in the human body within 6 to 8 weeks and can be preserved at room temperature for up to three years which cater to vital clinical and storage needs.

Who Are The Primary Market Leaders In The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

What Regional Factors Are Accelerating Growth In The Hemostatic Agents Market?

North America was the largest region in the hemostatic agents market in 2024. The regions covered in the hemostatic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2025, By The Business Research Company

Hemostasis Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Hepatitis Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Absorbable Hemostats Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Hemostatic Agents Market From 2025 to 2029?

The market for hemostatic agents has seen robust growth in the past few years. The market size which stands at approximately $4.19 billion in 2024 will escalate to $4.42 billion in 2025, yielding a compound annual growth rate (CAGR) of 5.5%. The past growth in this market can primarily be traced back to the increasing global population age, an upsurge in trauma and accident incidents, a higher frequency of cardiovascular diseases, an escalating number of bleeding conditions like hemophilia, and an increasing patient count suffering from liver diseases and coagulation abnormalities.

In the coming years, robust growth is anticipated for the hemostatic agents market size, predicted to expand to $5.43 billion by 2029 with a CAGR of 5.3%. The surge in market size during the forecast period is linked to the rising number of surgical procedures, the increase in demand for minimally invasive surgeries, growing popularity for orthopedic and aesthetic surgeries, as well as a heightened demand for hemostasis in dental surgery. Key trends for the forecast period encompass progress in hemostatic agent formulas, the appearance of bioengineered and recombinant agents, improved product shelf-life and stability, the creation of combination items, and the invention of synthetic and absorbable hemostats.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

What Elements Are Contributing To Growth In The Hemostatic Agents Market?

The hemostatic agents market is set to witness increased growth due to the growing number of surgical procedures. These procedures are medical operations conducted by healthcare providers using specialized tools to diagnose, repair or excise body parts for health reasons. The uptick in surgeries is predominantly due to the higher prevalence of chronic diseases, which often necessitate surgical intervention to manage and enhance patient health outcomes. Hemostatic agents play a crucial role during surgical procedures as they expedite the blood clotting process, minimize blood loss and enhance field of view for better precision. For example, reports from the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK-based professional body, indicate that there was a 102% increase to 31,057 in cosmetic procedures in 2022, compared to the previous year. Furthermore, women accounted for 93% of all these procedures, marking a 101% increase from 2021. As such, the surge in surgical procedures is fuelling the expansion of the hemostatic agents market.

Which Segments Are Detailed In The Global Hemostatic Agents Market Report?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

Which Emerging Trends And Strategic Shifts Are Shaping The Hemostatic Agents Market?

Leading organizations in the hemostatic agents market are investing in the creation of cutting-edge solutions like collagen-based hemostats aimed at providing swift, efficient hemostasis and tissue sealing for both minimally invasive and traditional surgeries. Collagen-based hemostats, composed from purified collagen, are used to facilitate blood clotting at injury or surgical incision locations by amplifying the body’s inherent clotting mechanism. For example, in March 2025, Baxter, a healthcare firm based in the US, introduced its product, HEMOPATCH Sealing Hemostat, a pad that can be absorbed and is made from collagen. This advanced pad features a dual-action approach that merges a collagen matrix with a NHS-PEG layer that transforms into a hydrogel when it contacts moisture, causing bleeding sites to seal immediately. The pad firmly adheres to moist tissues, making it apt for both minimally invasive and traditional surgeries where other hemostats may not work as effectively. The patch achieves hemostasis in less than two minutes and it does not require temperature-dependent storage or special setup, simplifying the surgical process. It also disintegrates naturally in the body between six and eight weeks and can be kept at room temperature for as long as three years, fulfilling key clinical and storage prerequisites.

Who Are The Key Contributors To Growth In The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

Which Region Is Projected To Lead The Hemostatic Agents Market By 2025?

North America was the largest region in the hemostatic agents market in 2024. The regions covered in the hemostatic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model